Follow by Email

Monday, July 02, 2012

Diabetes patient gets highest-ever compensation in class-action suit against Israeli drug company

http://www.haaretz.com/news/national/diabetes-patient-gets-highest-ever-compensation-in-class-action-suit-against-israeli-drug-company-1.448282


The highest-ever award in an Israeli class-action suit against a drug manufacturer – NIS 12.1 million – was recently made under a compromise agreement reached between a diabetes patient and GlaxoSmithKline, the maker of Avandia. The suit had been filed by a diabetic who claimed that GSK had concealed data from the public that showed the drug, which is used to treat people with type-2 diabetes, increased the risk of dying from a heart attack. The award is expected to be used to fund a new treatment program for diabetics. In May 2007, the New England Journal of Medicine published an article by two researchers who did a meta-analysis of 42 trials of Avandia. The two were able to demonstrate that the drug increased the chance of heart attack by 43%, and the risk of dying from a heart attack by 64%, compared to diabetics who were treated with other drugs or were given placebos.

Those wonderful Israeli's - wanna bet it was only gullible goys who were given this drug!

No comments: